Folikülogenezisin Moleküler Temelleri

Oosit fertilizasyon ve embriyogenezis aşamalarını başarılı bir şekilde tamamlayabilmesi için bir takım kompleks hücre içi değişiklik aşamalarından geçmesi gerekir. Memelilerde oognezis erken fetal hayatta başlar ve doğumdan sonra da uzun yıllar devam eder. Oositin gelişim aşamalarında stoplazmasında yeni gen ve organel üretimi ve bunların yeniden dağılımı ve düzenlenmesi gerekmektedir. Özellikle bu dönemde stoplazmik organellerden mitokondrinin ve DNA moleküllerinin replikasyonu ve dağılımı kalıtsal bazı özelliklerin taşınması açısından hayati önem taşır. Anahtar kelimeler: Folikülogenezis, İnsan, Oosit Büyümesi

Anahtar Kelimeler:

Folikülogenezis, İnsan, Oosit Büyümesi

Molecular Basis of Folliculogenesis

The oocyte has a remarkable and complex life history and it is only at the completion of a varied set of intracellular changes that this cell finally acquires its full capacity to support fertilisation and embryogenesis. In mammals, oogenesis is initiated early in fetal development and ends months to years later in the sexually mature adult. During their growth phase oocytes acquire a complex cytoplasmic organisation dependent both on the production of new gene products and organelles, and on the modification and redistribution of existing ones. The fidelity of replication of cytoplasmic organelles during oogenesis, especially mitochondria and their DNA molecules, is crucial as cytoplasmic inheritance of the zygote is mostly, if not exclusively, derived from the egg. Key words: Folliculogenesis, Human, Oocyte Growth

Keywords:

Folliculogenesis, Human, Oocyte Growth,

PDF

___

Epifano O, Dean J. Genetic control of early folliculogenesis in mice. Trends Endocrinol Metab 2002;13:169-73.
Minegishi T, Kishi H, Tano M, Kameda T, Hiakawa T, Miyamoto K. Control of FSH receptor mRNA expression in rat granulosa cells by 39,59-cyclic adenosine monophosphate, activin, and follistatin. Mol Cell Endocrinol 1999;149:71–7.
Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocrine Reviews 1996;17:121- 55.
Cecos F, Schwartz D, Mayaux MJ 1982 Female fecundity as a function of age. New England Journal of Medicine 1982;306:404- 6.
Piette C, de Mouzon J, Bachelot A, Spira A. In-vitro fertilization: influence of women's age on pregnancy rates. Human Reproduction 1990;5:56-9.
McGee EA, Hsueh AJ. Initial and cyclicrecruitment of ovarian follicles. Endocr Rev 2000; 21:200–14.
Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 1999;140:5789–96.
Valdimarsson G, De Sousa PA and Kidder GM. Coexpression of gap junction proteins in the cumulus–oocyte complex Molecular Reproduction and Development 1993;36:7–15.
Li R, Mather JP. Lindane, an inhibitor of gap junction formation, abolishes oocyte directed follicle organizing activity in vitro. Endocrinology 1997;138:4477–80.
Dietl J. Ultrastructural aspects of the developing mammalian zona pellucida. In Dietl, J. (ed.), The Mammalian Egg Coat. Springer-Verlag, Berlin 1989, pp, 49-60.
Bleil JD, Wassarman PM. Structure and function of the zona pellucida: identification and characterization of the proteins of the mouse oocyte's zona pellucida. Dev. Biol 1980;76:185-202.
Kumar TR, Wang Y, Lu N, Matzuk MM. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat. Genet 1997;15:201-4.
Bornslaeger EA, Mattei P, Schultz RM. Involvement of cAMP dependent protein kinase and protein phosphorylation in regulation of mouse oocytematuration. Dev Biol 1986: 114;453- 62.
Richards JS, Russell DL, Ochsner S, Espey LL. Ovulation: new dimensions and new regulators of the inflammatory-like response. Annu Rev Physiol 2002;64:69-92.
Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15: identification of target cells and biological functions. J Biol Chem 2000;275:39523-8.
Yan, C, Wang, P, DeMayo, J, DeMayo, F.J, Elvin, J.A, Carino, C, Prasad, SV, Skinner, SS, Dunbar, BS, Dube, JL. et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol. Endocrinol, 2001;15:854-66.
Carabatsos, M.J., Elvin, J., Matzuk, M.M. and Albertini, D.F. Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice. Dev Biol, 1998: 204;373- 84.
Wiktor-Jedrzejczak W, Gordon S. Cytokine regulation of the macrophage (Mf) system studied using the colony stimulating factor-1-deficient op/op mouse. Physiol Rev 1996;76:927–47.
Pollard J, W Stanley ER. Pleiotropic roles for CSF-1 in development defined by the mouse mutation osteopetrotic (op). Adv Dev Biochem 1996;4:153–93.
Axel PN. Anti-Müllerian Hormone: It’s role in follicular growth initiation and survival and as an ovarian reserve marker. J Natl Cancer Inst 2005;34:18–21.
Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 1999;140:5789–96.
Weenen C, Laven JS, Von Bergh AR, Cranfi eld M, Groome NP, Visser JA, et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77–83.
Behringer RR, Finegold MJ, Cate RL. Mullerian-inhibiting substance function during mammalian sexual development. Cell 1994;79:415–25.
Tesarik J, Mendoza C. Nongenomic effects of 17b-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab 1995;80:1438–43.
Pelletier G, El-Alfy M. Immunocytochemical localization of estrogen receptorsa andb in the human reproductive organs. J Clin Endocrinol Metab 2000;85:4835–40.
Bukovsky A, Caudle MR, Svetlikova M, Upadhyaya NB. Origin of germ cells and formation of new primary follicles in adult human ovaries. Reprod Biol Endocrinol 2004:28;2:20.
Celik O, Esrefoglu M, Hascalik S, Gul M, Tagluk ME, Elter K, Aydin E, Use of porcine small intestinal submucosa to reconstruct an ovarian defect, Int J Gynaecol Obstet 2009;106:218-22.